Mark Kleinman isSky News’City Editorand the man who gets the Square Mile talking in his weekly City AM column. Today, he ...

Speculation is mounting GlaxoSmithKline's CEO Emma Walmsley may pay the price ... about the company’s R&D strategy, which Walmsley has left in the hands of Hal Barron, who made his name at ...

Now that is punchy. Even by the standards of boundary-pushing UK company boards, GSK’s decision to hand Dame Emma Walmsley, a potential pay package of more than £21.5m as part of a new ...

Was Emma Walmsley, CEO of GSK ... up $328.6 million year-on-year. On the other hand, its net income margin, although up year-on-year and quarter-on-quarter to 5.1%, remains below that of its ...

GlaxoSmithKline chief executive Emma Walmsley was no doubt hoping that an ... and expertise to match their respective tasks at hand," it argues. Boiling the letter down to the basics, the hedge ...

Emma Walmsley, chief executive of GSK ... with this on track to rise to 64p per share for 2025. It will also hand out a further £2 billion to shareholders as part of a buyback programme over ...

One of the lowest paid CEOs in pharma—and one of the only woman leading a top-tier giant—is set to receive up to $27.2 ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. While it revealed (PDF) that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...